JPMorgan Chase & Co’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
+41,107
| New | +$208K | ﹤0.01% | 4436 |
|
|
2025
Q1 | – | Sell |
-178,532
| Closed | -$646K | – | 6634 |
|
|
2024
Q4 | $646K | Buy |
178,532
+147,092
| +468% | +$532K | ﹤0.01% | 4038 |
|
|
2024
Q3 | $55.3K | Buy |
31,440
+10,754
| +52% | +$18.9K | ﹤0.01% | 4955 |
|
|
2024
Q2 | $32.3K | Sell |
20,686
-13,168
| -39% | -$20.5K | ﹤0.01% | 5041 |
|
|
2024
Q1 | $66K | Buy |
33,854
+21,987
| +185% | +$42.9K | ﹤0.01% | 4875 |
|
|
2023
Q4 | $16.7K | Sell |
11,867
-37,775
| -76% | -$53.3K | ﹤0.01% | 5282 |
|
|
2023
Q3 | $78.4K | Sell |
49,642
-9,657
| -16% | -$15.3K | ﹤0.01% | 4746 |
|
|
2023
Q2 | $128K | Sell |
59,299
-75,569
| -56% | -$163K | ﹤0.01% | 4526 |
|
|
2023
Q1 | $283K | Buy |
134,868
+132,271
| +5,093% | +$278K | ﹤0.01% | 4124 |
|
|
2022
Q4 | $6K | Buy |
+2,597
| New | +$6K | ﹤0.01% | 5201 |
|
|
2020
Q4 | – | Sell |
-6
| Closed | – | – | 5129 |
|
|
2020
Q3 | $0 | Buy |
6
+1
| +20% | – | ﹤0.01% | 5055 |
|
|
2020
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 4991 |
|
|
2018
Q1 | – | Sell |
-2,151
| Closed | -$105K | – | 4802 |
|
|
2017
Q4 | $105K | Buy |
2,151
+2,022
| +1,567% | +$98.7K | ﹤0.01% | 3888 |
|
|
2017
Q3 | $9K | Buy |
+129
| New | +$9K | ﹤0.01% | 4068 |
|
|
2016
Q3 | – | Sell |
-3,087
| Closed | -$120K | – | 4280 |
|
|
2016
Q2 | $120K | Sell |
3,087
-23,545
| -88% | -$915K | ﹤0.01% | 3349 |
|
|
2016
Q1 | $1.47M | Sell |
26,632
-207
| -0.8% | -$11.4K | ﹤0.01% | 2509 |
|
|
2015
Q4 | $3.69M | Buy |
26,839
+827
| +3% | +$114K | ﹤0.01% | 2096 |
|
|
2015
Q3 | $3.74M | Buy |
26,012
+12,708
| +96% | +$1.83M | ﹤0.01% | 2095 |
|
|
2015
Q2 | $3.45M | Buy |
+13,304
| New | +$3.45M | ﹤0.01% | 2273 |
|